US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist

41.430
+2.070+5.26%

Close Jan 2 16:00 ET

41.660
+0.230+0.56%

Post 20:01 ET

3.54BMarket Cap-14.85P/E (TTM)

CRISPR Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CRISPR Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 11.598M	--
--	2024/Q4	-- / 7.768M	--
--	2024/Q3	602.000K / 7.132M	--
--	2024/Q2	517.000K / 13.613M	--
--	2024/Q1	504.000K / 26.494M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 11.598M--

--2024/Q4-- / 7.768M--

--2024/Q3602.000K / 7.132M--

--2024/Q2517.000K / 13.613M--

--2024/Q1504.000K / 26.494M--

Unlock Free Earnings Estimates

Open Account

CRISPR Therapeutics Earnings Reports

CRISPR Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 5, 2024 09:16 ET

CRISPR Therapeutics | 8-K: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Nov 5, 2024 09:06 ET

CRISPR Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 5, 2024 16:13 ET

CRISPR Therapeutics | 8-K: CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Aug 5, 2024 16:09 ET

Analyst Rating

Updated: Dec 31, 2024

Buy

Buy
52.63%
Hold
36.84%
Sell
10.53%

Price Target

No Data

Heat List

Overall

No Data